Gabapentin
Product Images NDC 42254-109

This appears to be a table with various symptoms and their occurrences for patients taking Gabapentin tablets versus a placebo. The symptoms are divided into several body systems including the whole body, digestive system, metabolic and nutritional disorders, skin and appendages, and special senses. The table shows the number of patients experiencing each symptom for both Gabapentin and placebo groups. Some of the symptoms include asthenia, infection, headache, accidental injury, diarrhea, dry mouth, dizziness, somnolence, rash, and amblyopia. There is a note indicating that blued vision was reported.*

This text provides a useful description of the possible adverse events associated with Gabapentin tablets®. It lists various body systems and their related adverse conditions, such as fatigue, weight increase, back pain, and peripheral edema in the body as a whole. Similarly, it mentions dyspepsia, mouth or throat dryness, dental abnormalities, constipation, increased appetite, and leukopenia in the digestive system. Myalgia, fracture, somnolence, dizziness, ataxia, nystagmus, tremor, nervousness, dysarthria, amnesia, depression, thinking abnormal, tutching, and abnormal coordination are the nervous system-related adverse events. Moreover, Rhintis, pharyngitis, and coughing are the respiratory system-related adverse events, while abrasion and pruritus are the skin and appendages-related adverse events. The text also mentions impotence, diplopia, and laboratory deviations such as decreased WBC as the adverse events associated with the urogenital system and special senses, respectively.*

This is a table presenting adverse events that occurred when Gabapentin tablets® were compared to Placebo*® during a clinical trial with 128 participants. The body system and adverse events are listed. Some adverse events reported for the body as a whole include viral infection, fever, weight increase, fatique, and nausea and/or vomiting. Adverse events reported for the nervous system include somnolence, hostility, emotional lability, dizziness, hyperkinesia, bronchitis, and respiratory infection. Pius background antiepileptic drug therapy was used during the trial.*

This is a medical table that shows recommended dose regimens and supplement dosages for patients with different levels of renal function. The table includes creatinine clearance rates and corresponding dose ranges in milligrams for various medications. For patients who undergo hemodialysis, there are also post-hemodialysis supplemental dose recommendations. The table advises adjusting the daily dose according to the patient's creatinine clearance rate, and specifies a maintenance dose based on creatinine clearance estimates and a supplemental dose after hemodialysis for patients on hemodialysis.*

This prescription drug is Gabapentin 600mg tablets packaged by Physician Partner and RX only. It's used for treating seizures and nerve pain caused by herpes or shingles. It's manufactured by Glanmark Generics Ltd in India. Keep it at a temperature range of 15°C to 30°C (59°F to 86°F) and away from children.*

This is a description of a medication called Gabapentin in 800mg dose, produced by Glenmark Generics Ltd in India. The tablet is oval-shaped, white to off-white and contains Gabapentin USP. The product ID is QG010990 and it is for RXOnly, meaning only available with a prescription. It should be kept at a controlled room temperature. There is some additional text, but it cannot be read as it appears to be garbled or not in English.*